Drug intelligence / Profile preview

Theraprofen

Development stage
Unknown
Lead developer
Targeted Medical Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

**Theraprofen** is a prescription co-packaged oral product developed by Targeted Medical Pharma and marketed through Physician Therapeutics. It contains ibuprofen tablets, a nonsteroidal anti-inflammatory drug, together with Theramine capsules, a proprietary medical food intended for dietary management of metabolic processes associated with pain disorders and inflammatory conditions. Ibuprofen provides analgesic and anti-inflammatory activity through reversible, nonselective inhibition of cyclooxygenase enzymes and consequent reduction of prostaglandin synthesis; Theramine is intended to provide nutritional support for pain-related metabolic and neurotransmitter pathways. Theraprofen was evaluated in a Phase 4 randomized, double-blind study in chronic low back pain. The product was listed in DailyMed as an unapproved drug product. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b720c99f-feaa-4453-ba4a-c3377501f7b8))

Brand names
TheraprofenTheraprofen-60Theraprofen60Theraprofen 60Theraprofen-800Theraprofen800Theraprofen 800Theraprofen-90Theraprofen90Theraprofen 90
02

Targets

GABAA (Gamma-aminobutyric acid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Theraprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theraprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call